Yuansheng Hu

机构：Sinovac Biotech

发表论文 46 篇 · 总被引 2701 次 · h-index 15

代表论文

• Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial (2020 · The Lancet Infectious Diseases · 被引 1510)
• A serological aptamer-assisted proximity ligation assay for COVID-19 diagnosis and seeking neutralizing aptamers (2020 · Chemical Science · 被引 112)
• Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial (2020 · medRxiv · 被引 96)
• Translating daily COVID-19 screening into a simple glucose test: a proof of concept study (2021 · Chemical Science · 被引 62)
• Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trial (2018 · Vaccine · 被引 30)
• Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6–35 months in China (2020 · Human Vaccines & Immunotherapeutics · 被引 19)